|
James B. Breitmeyer has served as our Executive Vice President Development and Chief Medical Officer since August 2006. From December 2001 until August 2006 Dr. Breitmeyer served as Chief Medical Officer and Vice President Pharmaceutical Operations of Applied Molecular Evolution (AME) a wholly-owned subsidiary of Eli Lilly and Company a global pharmaceutical company. From February 2000 to July 2001 Dr. Breitmeyer was President and Chief Executive Officer of the Harvard Clinical Research Institute. Prior to February 2000 Dr. Breitmeyer held a various positions of increasing responsibility including Senior Vice President and Chief Medical Officer of Serono International S.A. a global biopharmaceutical company. | 